A companion tranche is the class of bonds inside a collateralized mortgage obligation that absorbs the unpredictable swings in homeowner prepayments so that paired Planned Amortization Class (PAC) bonds can pay on a fixed schedule. In exchange for soaking up that volatility, companion tranches — also called support bonds — carry higher yields than the PACs they protect. They are among the most interest-rate-sensitive instruments in the fixed-income market, and the trade-off at the center of owning one is simple to state and hard to live with: you get paid more to accept that your principal may come back far faster or far slower than the issuer’s base-case projection.
How a Companion Tranche Works Inside a CMO
A CMO slices the cash flows from a pool of mortgages into separate bond classes with different payment priorities. The most common structure pairs a PAC bond with one or more companion tranches. The PAC is designed to receive principal on a scheduled amortization regardless of what the underlying homeowners are doing. The companion makes that promise work by taking whatever principal does not fit the PAC’s schedule.
Fast prepayments? The overflow flows to the companion. Slow prepayments? The companion is cut off from principal first so the PAC can stay on track. This priority is written into the pooling and servicing agreement and the prospectus supplement, and the servicer applies it mechanically. There is no discretion. The companion bondholder accepts that structural uncertainty in return for a yield premium over what PAC holders earn.
The whole arrangement is possible because of the Real Estate Mortgage Investment Conduit structure in the federal tax code. Under 26 U.S.C. § 860A, a qualifying REMIC pays no entity-level federal income tax; income passes through to bondholders.1Office of the Law Revision Counsel. 26 USC 860A – Taxation of REMICs
Contraction Risk When Prepayments Speed Up
When interest rates fall, homeowners refinance. Refinancing retires the original mortgage early, and that wave of unscheduled principal hits the CMO trust all at once. The PAC receives exactly its scheduled amount; everything above that flows to the companion. The companion’s principal balance drops far faster than anyone projected at issuance.
This is contraction risk. A support bond originally expected to pay down over ten years might be fully retired in five if refinancing stays elevated. You get your principal back, but total interest earned shrinks because the outstanding balance declines so quickly. And that principal comes back during a period of falling rates, forcing you to reinvest at lower yields. If you bought the companion at a premium above par, the pain is worse: principal purchased at a premium gets returned at par.
As long as the prepayment rate stays within or above the upper boundary of the PAC’s protection range, the companion is the primary outlet for overflow principal. The PAC holders barely notice the spike in refinancing. The companion absorbed the entire disruption.
Extension Risk When Prepayments Slow Down
Rising rates flip the problem. Homeowners have no incentive to refinance into a higher rate, so prepayments drop sharply. The limited principal coming into the trust goes first to the PAC. The companion gets whatever is left, which may be nothing at all. In some months the companion bondholder collects interest but sees zero reduction in principal balance.
This is extension risk, and it can be severe. A support bond projected to start returning principal in year seven might not see a dollar of principal until year twelve or later. Your capital is locked into a coupon set at issuance even as new bonds in the market offer higher yields. The bond’s price in the secondary market drops, sometimes steeply, because buyers demand a discount to compensate for the below-market coupon and the uncertain timeline.
Market participants modeling these scenarios sometimes see the weighted average life of a companion tranche stretch from five years to twenty or more under stress assumptions. That range dwarfs anything you would see in a conventional bond.
How Tranche Sizing Sets the PAC Band
The protection a PAC bond actually offers depends almost entirely on the relative size of the companion tranche sitting beside it. That protection is expressed as a PAC band, a range of prepayment speeds within which the PAC will stay on its scheduled amortization. Prepayment speeds are measured against the PSA model, so a band might be quoted as 85–300 PSA. A larger companion relative to the PAC widens the band because there is more capacity to absorb excess or deficit principal. A smaller companion narrows it.
Once the companion is exhausted, either fully retired by fast prepayments or rendered irrelevant by extremely slow ones, the PAC loses its buffer. The market calls the result a “busted PAC,” and from that point the former PAC behaves like an ordinary sequential-pay bond exposed to the full volatility of the underlying mortgages. For companion buyers, the practical takeaway is that two tranches with similar yields can sit behind very different PAC bands, and the band is where the real risk profile lives.
Agency vs. Non-Agency Companion Tranches
Most CMOs in the market are agency deals issued or guaranteed by Ginnie Mae, Fannie Mae, or Freddie Mac. Ginnie Mae carries the full faith and credit of the U.S. government. Fannie Mae and Freddie Mac guarantee timely principal and interest, backed by their status as government-sponsored enterprises. For companion tranches inside these structures, credit risk is effectively off the table. Prepayment risk is the dominant variable driving price and return.
Non-agency CMOs have no government or GSE guarantee. Companion tranches in those deals carry both prepayment risk and credit risk, and they are substantially more volatile. Analyzing an agency companion is a prepayment-modeling exercise. Analyzing a non-agency companion requires layering in default and loss assumptions as well. Treating the two as comparable is a common and costly mistake.
Why Companion Tranches Are Hard to Value
Pricing a companion tranche is harder than pricing most bonds because the cash flows depend on the path interest rates take, not just where they end up. Two rate scenarios that arrive at the same endpoint through different routes can produce very different prepayment patterns and very different returns. This path dependence makes standard yield-to-maturity analysis nearly useless.
The market instead relies on Option Adjusted Spread (OAS), which attempts to measure the yield premium an investor earns after accounting for the prepayment option embedded in the underlying mortgages. OAS is calculated by running hundreds or thousands of simulated interest-rate paths, projecting prepayment behavior under each, and computing the spread over the benchmark curve that equates the modeled cash flows to the market price.
OAS is a useful starting point with real limits. The number varies with the prepayment model used, the bond’s coupon relative to current rates, and the seasoning of the underlying mortgages. Treating OAS as fixed rather than model-dependent leads to overconfidence in relative-value calls. Two companion tranches showing the same OAS can behave very differently in a rate move, and experienced CMO traders supplement the metric with scenario analysis — stress-testing specific prepayment assumptions rather than relying on the model’s average.
Tax Treatment: OID Accrues Even When Cash Doesn’t Arrive
REMIC regular interests, including companion tranches, are treated as debt instruments for federal income tax purposes.2Office of the Law Revision Counsel. 26 USC 860C – Taxation of REMICs That classification triggers the original issue discount rules, which can create a meaningful gap between the cash you receive in a year and the taxable income you must report.
Under 26 U.S.C. § 1272, OID on a REMIC regular interest must be included in income as it accrues, regardless of whether cash has been received. Because principal on a companion is subject to acceleration or delay depending on prepayments, the statute requires OID to be calculated using a prepayment assumption rather than a fixed maturity date. The daily accrual is recomputed each period based on the present value of remaining payments, the original yield to maturity, and actual prepayment experience to date.3Office of the Law Revision Counsel. 26 USC 1272 – Current Inclusion in Income of Original Issue Discount
You do not compute OID yourself. The REMIC’s issuer or its agent calculates accrual amounts and reports them on a Consolidated Form 1099. If you buy a companion in the secondary market at a price different from its adjusted issue price, you may need to adjust the reported OID for acquisition premium or market discount. One small relief: if the OID on your bond falls below a de minimis threshold (less than one-quarter of one percent of the stated redemption price times the number of full years to maturity), you do not have to report it.
Who Companion Tranches Are Appropriate For
Regulators treat these bonds as high-risk, and the sales rules reflect that. FINRA Rule 2111 requires a broker-dealer recommending a security to have a reasonable basis for believing the recommendation is suitable given the customer’s age, financial situation, risk tolerance, time horizon, and investment experience. The rule imposes three obligations: the firm must understand the product well enough to know it is appropriate for at least some investors, must determine it fits the specific customer, and must ensure repeated recommendations are not excessive in the aggregate.4Financial Industry Regulatory Authority (FINRA). FINRA Rule 2111 – Suitability
FINRA Notice to Members 93-73 adds CMO-specific guidance. Firms and their representatives must be conversant in all characteristics of CMOs before recommending them and must ensure customers understand the risks. For high-risk tranches, a category that includes companion bonds, the firm must evaluate suitability based on the individual investor’s sophistication and risk profile and confirm the investor is aware of the specific risks involved.5Financial Industry Regulatory Authority (FINRA). Notice to Members 93-73 Not every CMO tranche is appropriate for every investor, and companion tranches sit at the high-risk end of that spectrum. If a broker is pitching one into a retail account without a serious conversation about contraction and extension risk, that is a problem worth raising before you buy.